December 20, 2024 - 05:39

In November, tax revenue for Germany's federal and state governments experienced a notable increase of 9.0% compared to the same month in the previous year, according to the finance ministry's monthly report. The total tax revenue reached 61.0 billion euros, equivalent to approximately $63.43 billion. This rise in revenue reflects a broader trend, with tax revenues increasing by 3.8% from January through November when compared to the same period last year, culminating in a total of 747.9 billion euros.
Despite this encouraging growth in tax revenue, the German government has issued a cautious economic outlook. It anticipates a contraction of 0.2% in the economy for 2024. If this forecast holds true, Germany would become the only member of the Group of Seven major industrial democracies to experience a decline in economic output for two consecutive years. This situation highlights the challenges facing the nation amid global economic uncertainties.
February 28, 2026 - 02:28
Why Axos Financial (AX) Shares Are Sliding TodayShares of Axos Financial experienced a sharp decline in Thursday`s trading session, mirroring a broader downturn across the financial sector. The digital bank`s stock fell nearly 9% following the...
February 27, 2026 - 23:14
House Finance Committee advances millionaires tax bill to full voteA landmark proposal to institute the first-ever income tax in Washington state has cleared a critical hurdle. The House Finance Committee voted to advance the bill, setting the stage for a full...
February 27, 2026 - 05:38
Super Group (SGHC) Limited (SGHC) Reports Financial Results For Fourth Quarter and Full Year 2025Super Group (SGHC) Limited, the parent company of leading global online sports betting and gaming brands, has released its financial results for the fourth quarter and full year ended December 31,...
February 26, 2026 - 20:17
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent ProgressCRANBURY, N.J., February 26, 2026—Rocket Pharmaceuticals, a late-stage biotechnology firm, has released its financial and operational results for the fourth quarter and full year ending December...